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The binding ofcertain immunoglobulins ("cytophilic" antibodies) to receptors
on the surface of macrophages probably plays a central role in a number of
macrophage functions, such as antibody-dependent cell-mediated cytotoxicity
(1-3), macrophage"arming" (4,5), and possiblyin the presentation ofantigens to
T and B cells in the induction of various immune responses. In this paper we
studied the kinetics, equilibrium constants, and the specificity ofthe bindingof
various myeloma proteins by normal and thioglycollate-stimulated peritoneal
macrophages andby a macrophage-like cell line, P388D, (1). The resultsdemon-
strate that proteins ofthe IgG2a class are bound with particularly high affinity
to all of these cells. The rapid rates of association and dissociation of these
proteins indicate that the macrophage surface is in rapid equilibrium with
immunoglobulins (Igs) in the cell's immediate microenvironment. The macro-
phage receptors for Igs ofthis class are readily removed with trypsin and they
can be regenerated by continued cultivation in the absence of serum protein.
Materials and Methods
Cell Culture.
￿
P388D, cells, obtained from John Wunderlich (NIH, Bethesda, Md.) were grown
in sealed spinners in alpha modified minimum Eagle's medium, (MEM) (6) with 10% fetal calf
serum(FCS),' heat inactivated at 56*C for30 min. Peritoneal macrophages were obtained from 20-
30 gfemale C57BL/6J mice (The Jackson Laboratory, BarHarbor, Maine);some ofthe mice were
injected 4 days previously with 1 ml of thioglycollate medium, andperitoneal cellswere collected
as described (7). Cell yieldfrom thethioglycollate-stimulatedanimals was4 x 107 cells/mouse, of
which 70%were macrophages. Unstimulated mice yielded 5 x 108cells/mouse, ofwhich 30% were
macrophages; the remainder were mostly lymphocytes. Unstimulated and thioglycollate-stimu-
lated cells were plated at densities of 2 x 108 and 7 x 105 cells, respectively, in 16-mm diameter
tissue culture wells (Linbro Scientific Co., New Haven, Conn.), which were coated with purified
bovine fibrinogen (8) at 10 wg/cm2; fibrinogen (3 mg/ml) in phosphate-buffered saline (PBS) was
diluted to 0.1 mg/ml in water, and 0.2-ml portions were used to coat the wells, whichwere then
dried at 45°C. Normal macrophages, in particular, spread and adhered better on such dishes.
* Supported in part by a research grant (CA-15472) and a grant to the MIT Center forCancer
Research (CA-14051) from theNational Cancer Institute, National Institutes ofHealth; additional
support was provided by the James and Lynelle Holden Fund.
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' Abbreviations used in this paper: BSA, bovine serum albumin; FCS, fetalcalf serum; HBSS,
Hanks' balanced salt solution; MEM, alpha modified minimal Eagle's medium; PBS, phosphate-
buffered saline, 0.15 M NaCl-0.01 M K phosphate, pH 7.4; PBS-BSA, PBS containing 2 mg/ml of
BSA.
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P388D, macrophages were plated at densities from 2 to 8 x 105 cells/well. Plates were maintained
at 37°C in a 5% C02-air mixture.
Cell Counting .
￿
Adherent macrophages cannot be dispersed with trypsin, and it was therefore
difficult to enumerate the plated cells. Accordingly, we resorted to counting nuclei in cell lysates.
After washing with PBS, cells were lysed with 0.5% Triton X-100 in PBS containing 5 mM EDTA.
The lysate, containing dispersed nuclei, was diluted in 20 ml of PBS and counted in a Coulter
counter (Coulter Electronics Inc., Hialeah, Fla.) using a 140 gm aperture. The results were in good
agreement with the number of P388D, cells plated over a wide range of dilutions.
Myeloma Proteins.
￿
The following proteins of indicated subclasses were used : MOPC-104E,
IgM; MOPC-21, IgGl; LPC-1 and 5563, IgG2a; MPC-11, IgG2b; and T-15, IgA. The corresponding
tumors were obtained from Dr. Michael Potter, National Cancer Institute, Bethesda, Md., or from
Litton Bionetics, Inc., Silver Springs, Md., and were maintained by serial passage as subcuta-
neous tumors in BALB/cJ and BALB/cAnN mice. Serum containing protein 5563 was a generous
gift from Dr. George D. Sorenson, Dartmouth Medical School, Hanover, N. H. Ammonium sulfate
was added to 45% ofsaturation to ascites fluid or serum from animals bearing the various tumors.
Precipitates were dissolved in 150 mM NaCl, 10 mM Tris-HCI, pH 8, and dialyzed against the
same buffer. After chromatography on Sephadex G-200, the 195 peak of the IgM protein (MOPC-
104E) was purified by affinity chromatography on dextran (9). The other proteins were purified by
ion-exchange chromatography on QAE-A50. MOPC-21 and MPC-11(50 mg each) were dialyzed vs.
50 mM NaCl, 25 mM Tris-HCl, pH 7.5, loaded onto a QAE-A50 column (1.8 x 29 cm), washed with
two column volumes ofthe same buffer, and then eluted with 250 ml of a 0.05-0.7 M NaCl gradient
in 25 mM Tris-HCI, pH 7.5. MOPC-21 eluted at 0.27 M NaCl, and MPC-11 at 0.43 M NaCl. LPC-1
and 5563 (50 mg each) were dialyzed vs. 50 mM NaCl, 25 mM Tris-HCl, pH 9.1, loaded onto a QAE-
A50 column (1.8 x 25 cm), and eluted with 250 ml of a 0.05-0.7 M NaCl gradient in 25 mM
Tris-HCI, pH 9.1. Both proteins eluted at 0.34 M NaCl. Each ofthe proteins was dialyzed against
PBS and stored at 4°C in the presence of 0.02% Na azide. To avoid aggregation the myeloma
proteins were not frozen.
Fc and Fab.
￿
Purified LPC-1 (30 mg) in 10 ml ofPBS containing 0.1 M 2-mercaptoethanol and 2
mM EDTA was incubated at 37°C with 0.34 mg papain (10). After 2 h no 7S Ig was present, as
judged by chromatography on Sephadex G-200. After dialysis at 4°C against 50 mM NaCl, 50 mM
Tris-HCI, pH 8.8, the reaction mixture was passed over a QAE-A50 column (0.8 x 20 cm) in the
same buffer: the Fab fraction was not retained, and the Fc fraction was eluted with 0.4 M NaCl, 50
mM Tris, pH 8.8. Both fractions were dialyzed against PBS and concentrated by vacuum dialysis.
Of an initial 30 mg of LPC-1 the final yield was 8.5 mg Fc and 16.2 mg Fab, assuming the same
extinction coefficient for the intact Ig and its fragments (E;cm = 14 .0).
Iodination .
￿
Proteins were iodinated by a slight modification of the chloramine T method of
Sonoda and Schlamowitz (11). Routinely, 50 wg ofprotein were iodinated with 0.5 mCi ofcarrier-
free [1251]Na (New England Nuclear, Boston, Mass.), and chloramine T at a 15-fold molar excess
over the protein. The reaction was terminated after 30 min at 0°C by addition of0.1 ml of a 0.04%
tyrosine solution. After addition of 0.01 ml of 1 M KI, the reaction mixture was chromatographed
on Sephadex G25 equilibrated with PBS containing 2 mg/ml ofbovine serum albumin (PBS-BSA).
This procedure usually resulted in 50% incorporation of the added 1251, corresponding to 0.2 atoms
1251 per molecule of IgG. Increase in the amount of chloramine T to 50- or 100-fold molar excess
improved the yield slightly (to ,-80%), but resulted in denaturation, as evidenced by high
backgrounds and nonlinearity in binding curves (see below). A trace amount of each iodinated
protein (except 104E) in the presence of a large excess of the corresponding unlabeled myeloma
protein was subjected to isoelectric focussing in 5% polyacrylamide slab gels containing 3 M urea
and 2% ampholines, pH 3-10, according to Sakato et al.2 Autoradiography revealed exact coinci-
dence ofthe labeled and unlabeled protein, suggesting that there was little oxidation ofcysteine to
cysteic acid by the chloramine T. Iodinated proteins were stored at 4°C and used for no longer than
3 or 4 wk.
Binding Assays.
￿
Cultured cells in 16 mm tissue culture wells were washed twice with Hanks'
balanced salt solution (HBSS) and incubated in serum-free MEM containing 0.05% lactalbumin
hydrolysate for 2-12 h to allow dissociation or phagocytosis of membrane-bound Igs. The medium
2 Sakato, N., S. Hall, and H. N. Eisen. Manuscript in preparation.1522
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was then replaced with 0.19ml ofa 1:1 mixtureof PBS-BSA and L-15 culture medium containing
1251-proteinat thedesired specific activity. Aconstant inputof1251-proteinwasused in allwells(--8
x 104 cpm, 0.02 lig). After 30-60 min, theradioactive fluidwasaspirated and theunboundIg was
rapidly removed by dipping the culture plate three times in 1.5 liters of ice-cold PBS. To count
surface-bound 1251-protein, the cellswere incubated with 0.4 ml of 0.25% "1-300" trypsinin PBS at
37°C for 20 min andthe supernatewas removedfor assay. Neither the normal, thethioglycollate-
stimulated, northeP388D, macrophages were detached by thetrypsin treatment. Thebackground
in emptywellsor in wellscontaining mouseembryo fibroblasts as control cellswas0.2-0.5%ofthe
input radioactivity; the same background was obtained when macrophages were incubatedwith
the same amount of radiolabeled myeloma protein in the presence of a large excess of unlabeled
myelomaprotein (resulting in lowspecific activity, s6 x 105cpm/mg;seeFig. 3, below). Allassays
were in duplicate, and the variation from the mean usually did notexceed 10%.
Reagents were obtained andprepared as follows: FCS (FlowLaboratories, Inc., Rockville, Md.) ;
L-15 culture medium (Grand Island Biological Co., Grand Island, N. Y.) ; MEM, alpha modified
cell culture medium (K. C. Biological Inc., Lenexa, Kans.) ; fluid thioglycollate medium (Difeo
Laboratories, Detroit, Mich.); lactalbumin hydrolysate and trypsin 1-300 (Nutritional Biochemi-
cals Corp., Cleveland, Ohio); crystallized trypsin, twicecrystallized papain, and crystallized BSA
(Sigma Chemical Co., St. Louis, Mo.) ; crystallized, TPCK-treated trypsin (Worthington Biochemi-
cal Corp., Freehold, N. J.); soybean trypsin inhibitor, component VI, and bovine fibrinogen,
fraction I(Miles Laboratories Inc., MilesResearch Div., Kankakee, Ill.); and ampholines, pH 3-10
(LKB, Stockholm, Sweden).
Results
Kinetics of Uptake and Dissociation of IgG2a.
￿
1251-LPC-1 (1.1 N.g/ml) was
rapidly bound by P388D, macrophages (Fig. 1). The reaction followed pseudo-
firstorder kinetics (Fig. 1 B), and at4°C maximum binding by P388D, cells was
achieved at 60 min (Fig. 1 A). Binding was more rapid at higher temperatures
(Table I). Insubsequent experiments, a 60 min incubation was used at4°C and a
FIG. 1
￿
Binding of an IgG2a myeloma protein (LPC-1) to a macrophage cell line (P388D,).
5x 105 macrophages were incubated at 4°C with LPC-1 (1.1 ug/ml, 5 x 105cpm/Ag) for the
indicatedtimes, washed rapidlyin cold (4°C)PBS, andtreated with trypsin to release bound
Ig. Data are corrected for nonspecific binding (i.e. counts per minute bound in emptywells
or in wells with cultured fibroblasts, or to macrophage-containing wells treated with the
standard amount of 1251-proteinin thepresence of 1mg or more unlabeledmyelomaprotein).
(A)Time-course of association. (B) Plot ofdata in A according to afirst-order reaction (Igin
greatexcess). The valuefor a was the average counts per minute bound at 60- and 90-min
time points in A; x was counts per minute bound at earlier time points.JAY C. UNRELESS AND HERMAN N . EISEN
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TABLE I
Kinetic Constantsfor the Binding ofan IgG2a Myeloma Protein
(LPC-1) to a Macrophage Cell Line (P388D,)
Conditions wereas described in Figs. 1 and 2. For measurementsofdissocia-
tion rates the culture plates were washed in PBS at the same temperature
at which the incubation was carried out (1st column at left), before addition
of 0.5 ml of PBS-BSA.
30 min at other temperatures. Under the same conditions, the amount of LPC-1
bound by cultured mouse embryo fibroblasts and by empty wells was no more
than about 5% of the maximal amount bound by the macrophages.
The dissociation of LPC-1 from macrophages was investigated by following
release of the cell-bound Ig at various temperatures (Fig. 2 A). The dissociation
obeyed first order kinetics (Fig. 2 B), and the rate increased with increasing
temperature (Table I) . Thehalf times fordissociation (Tj) obtained from the first
order rate constants are summarized in Table I. The Tj at 4°C, 8.4 min, is long
compared to the time it takes to wash the plates free of nonbound Ig (15 sec) ;
thus, it was not necessary to correct for dissociation of bound Ig when subse-
quent measurements were made of the rate or extent ofbinding. The linearityof
the first order dissociation and pseudo-first order association kinetics suggest
strongly that LPC-1 interacts with asingle class ofreceptor molecules on thecell
surface.
Equilibrium Constant and Number of IgG2a Receptors Per Cell .
￿
P388D,
macrophages (8 x 101 cells per well) were incubated for 30-60 min with a
constant amount of '21I-LPC-1 and various amounts of unlabeled LPC-1. Fig. 3
shows a typical binding curve. As control, the binding to C57BL/6J embryo
fibroblasts was also measured. To derive equilibrium (association) constants and
number ofbinding sites per cell, the data were plotted accordingto rlc = Kar -
nr (Scatchard equation), where Ka is the equilibrium constant (in M-'), r is
micrograms Ig bound per well, c is unbound Ig in M, and n is the limiting
value forr as c becomes very large. The number ofcells per well was countedas
described (see Materials and Methods). To calculate the amount of specifically
bound Ig, the observed values were corrected by subtraction of counts per
minute bound in the presence of a large excess of unlabeled Ig ; this blank was
the same as that observed by incubating the labeled Ig with control fibroblasts
or in empty wells (Fig. 3). Fig. 4 A shows the Scatchard plots derived from
data obtained at differenttemperatures ; theresultingequilibrium constants(Ka
values) andnumber of bindingsites percell are summarized in Table II. TheKa
was considerably higher at 4°C than at 37°C, indicating that the reaction is
exothermal . The van't Hoff plot of this data (log Ka vs. 1/T), shown in Figure 4 B,
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FIG. 2.
￿
Dissociation of bound LPC-1 myeloma protein from P388D, macrophages . Macro-
phages were incubated for 60 min with LPC-1 as in Fig . 1, washed rapidly, and then
incubated in 0.5 ml of coldPBScontaining 2mg BSA/ml ; sampleswere removed for assay at
timed intervals . (A) Time-course of dissociation . (B) First-order plot ofdata in A ; the value
used fora was counts perminute released at completion of the reaction (average of counts
per minute dissociation at 60- and 90-min time points in A) ; x was counts per minute
dissociated at earlier time points .
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￿
Binding of 'z5I-LPC-1 to cultured cells as a function of the molarconcentration of
LPC-1 (mol wt, 150,000 daltons) . Cells were incubated at 4°C for 1hwith aconstant amount
of '25I-LPC-1 (0.024 Wg, 1 .18 x 105 cpm) and the indicated amounts ofunlabeled LPC-1 . The
data are not corrected for background binding: (0-0), 8 x 105 P388D, macrophages per
well ; (0-0), 1.2 x 105 C57BL/6J embryo fibroblasts per well .
suggests that binding varies with temperature, perhaps because ofchanges in
the fluidity of the cell membrane below 20°C (12) .
The bindingofLPC-1 was independentof cellular energy metabolism : neither
2,4-dinitrophenol (10-5 and 10-4 M) nor fluoride (10-3 and 10-2 M) had an effect
on binding . As others have found in examining the binding of aggregated Igs0.8
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The binding ofLPC-1 to P388D, macrophages at different temperatures. Except for
variations in temperatures the conditions were as in Fig. 3 . Unbound Igs were removed in
all instances with PBS at about 4°C, r, micrograms LPC-1 bound per well; c, unbound
concentration of LPC-1 in moles per liter. (A), Variation of binding with free concentra-
tion of LPC-1 at 4°C, ("-"); 20°C, (A-A); and 37°C, (O-O). (B) Variation of equilibrium
constants (K.) with absolute temperature (T).
TABLE II
Equilibrium (Association) Constants and Number ofSites Per Cell for Binding ofIntact
LPC-1 and 5563 Myeloma Proteins and the Fab and Fc Fragments ofLPC-1 to
Macrophages ofthe P388D, Line
1525
Conditions for binding of LPC-1 and 5563 are described in Figs. 3 and 4. The Fab and Fc frag-
ments were prepared as described. A constant input of 125I-Fab and 115I-Fc (0.05 IWg, 2 x 105 cpm)
was used; the amount of cold Fab or Fc was varied as described.
* The number of binding sites per cell was obtained by multiplying the moles of bound Ig at
saturation (abscissa intercept in Scatchard plot of Fig. 4) by Avogodro's number and dividing by
the number of cells per well, determined as described.
$ There was no detectable difference in the binding ofthe LPC-1 Fab fragment to macrophages and
to mouse embryo fibroblasts.
§ The mol wt ofthe Fc fragment was assumed to be 50,000 daltons.
and Ig-coatederythrocytes (RBCs) (13, 14), the bindingofmonomeric LPC-1 was
also independent ofdivalent cations: this protein in PBS-BSA was bound about
as well in the presence or absence ofEDTA (10 mM). Centrifugation ofboth the
iodinated and unlabeled LPC-1 preparations for 3 h in a 50.1 SW rotor of a
Beckman L65 ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.) at
Temperature
°C
Protein Ka
(M-')
Sites per cell*
4 LPC-1 1.1 x 10, 100,000
24 LPC-1 6.9 x 107 95,000
37 LPC-1 2.2 x 10' 110,000
37 5563 2.9 x 10' 100,000
37 LPC-1 Fab -$ -
37 LPC-1 Fc 4.4 x 108 180,000§1526
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45,000 rpm (sufficient to pellet approximately 40% ofthe unlabeled protein) did
not change the slope or intercept of the Scatchard plots. This observation and
the volume of elution of the LPC-1 preparation from Sephadex G-200 strongly
suggest thatthebound protein was monomericIg, rather than a small subset of
aggregated molecules.
Binding of Fab and Fc Fragments.
￿
The fragments prepared by papain
digestion ofLPC-1 were iodinated and tested for binding to P388D, cells. There
was no detectable binding of the Fab fragment. As compared with intact
molecules, the Fc fragments bound with slightly less affinity and to slightly
more binding sites (Table II). The receptors on P388D, cells are clearly specific
for the Fc domain of LPC-1.
Trypsin Sensitivity of the Fc Receptor.
￿
After treating P388D, macrophages
with trypsin (1 mg/ml crystallized trypsininPBS) for 15min at 37°C the cells no
longer bound LPC-1. However, when the trypsin-treated cells were incubated
for 12 h in serum-free medium they regenerated 60% of their LPC-1-binding
activity (Fig. 5). The receptors for LPC-1 on thioglycollate-stimulated macro-
phages were also sensitive to trypsin: theirbindingwasreduced 96%by treating
the cells with TPCK-treated trypsin (1 mg/ml) for 15 min at 37°C.
The effect ofinhibitors ofmacromolecule synthesis on the regeneration of Fc
receptors is shown in Fig. 6. After removing the receptors with trypsin as
described above, the P388D, cells were incubated for 8 h in medium with 10%
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FIG. 5.
￿
1'rypsin sensitivity oftheIgG2aFc receptor.After24 hin MEMcontaining serum,
P388D, macrophages (7 x 101) were washed and placed in serum-free MEM (with 0.05%
lactalbumin hydrolysate) for 12 h before assayat 37°C forbindingofLPC-1. Aftertreatment
with trypsin(1 mg/ml crystalline trypsin in PBS, 37°C, 15 min) thecellswere washed twice
with 0.5 ml portions of MEM containing 100 gg/ml soybean trypsin inhibitor, and twice
more with HBSS. (0-0), control, no trypsin treatment; (0-0), treated with trypsin
before the 12-h incubation in serum-free medium before assay; and (O-0), treated with
trypsin immediately before assay.JAY C . UNKELESS AND HERMAN N. EISED
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Effects of actinomycin D and cycloheximide on the regeneration of Fc receptors
after treatment of P388D, macrophages with trypsin. 12 h after plating, P388D, cells (7 x
106) were treated with trypsin as described in Fig. 5 and incubated for 8 h in MEM
containing 10% heat-inactivated FCS and the indicated inhibitor. The cells were then
washed and incubated in serum-free L-15 medium at 37°C for 30 min before assay with LPC-
1 (1 mg/ml, 5 x 106 cpm/Ag) at 4°C . In the absence of inhibitors, trypsin-treated cells
regenerated 36% ofthe LPC-1 binding-activity of untreated controls during the 8-h incuba-
tion period; i.e., 100% activity in the plot corresponds to 36% of the activity of untreated
control cells. ("-"), actinomycin D; and (O-O), cycloheximide.
serum and cycloheximideor actinomycin D. Cycloheximide at 100 Wg/ml totally
inhibited recovery. At 1 and 10 p,g/ml of actinomycin D regeneration of LPC-1-
bindingactivity reached 30% ofthelevel in control cells, which hadbeen treated
with trypsin and incubated in the absence of the inhibitors. Additional controls,
in which cells were not treated with trypsin but incubated in presence of the
inhibitors, retained at least 80% of the binding activity, relative to untreated
P388D, cells. Cell loss due to trypsin or to inhibitor toxicity was negligible. The
results are consistent with either an internal pool of receptors (or receptor
subunits) whose assembly at thecell surface requires other protein synthesis, or
a somewhat stable messenger RNA (for the Fc receptor), whose translation is
blockedby cycloheximide. In either case theresultsestablish that the surface Fc
receptors are not simply adsorbed, but are produced by the cells that display
them.
Binding ofother Myeloma Proteins and Comparison ofNormal and Thiogly-
collate-stimulated Macrophages. With the binding assay described, a number
of other myeloma proteins were examined for cytophilic activity. In all cases,
C57BL/6J embryo fibroblasts were also used as binding controls. Over a wide
range of specific activities the binding of each labeled myeloma protein to
fibroblasts remained constant at 0.2-0.5% of the input radioactivity.1528
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Protein 5564, another IgG2a myeloma protein, bound to P388D1 cells with
nearly the same affinity constant as LPC-1. Titrationofthebindingof 1251-LPC-1
was performed as in Fig. 3 but in the presence of unlabeled protein 5563, at two
levels (5 and 25 p,g/ml). The binding of the radioactive IgG2a protein was
substantially inhibited by the unlabeled one, and the inhibition equilibrium
constant, Ki, estimated for protein 5563 was about the same as the KQ value
measured for the same protein in a direct binding titration, using 1251-5563.
From these results it appears that both of the IgG2a proteins were bound with
the same affinity to the same sites on the macrophage surface. These two
myeloma proteins have different isoelectric points : 5563 had four or five species
centered around pH 5.5 and LPC-1 had a number of bands centered at pH 7.3.
The differences probably reflect different amino acid sequences in the respective
VH domains, while the uniformity of binding to macrophages is consistent with
other evidence that these proteins are bound via CH domains (i.e ., with LPC-1
the Fc fragment was bound and the Fab fragments were not) .
As is shown in Figs. 7 A and 7 B, MPC-11 an IgG2b myeloma protein, was
weakly cytophilic ; at 4°C the KQ was 7 x 106 M-1, 20-fold less than the value for
IgG2a. Because ofthe low association constant (Table III) thefraction bound was
at most only fourfold over background; the binding of labeled MPC-11 to
embryonic fibroblasts remained constant over the range of specific activities
tested. Preliminary experiments suggest that there was mutual interference in
the binding of LPC-1 and MPC-11, but whether these proteins bind to the same
receptor or are mutually inhibitory because of steric hindrance is not clear.
None of the other myelomas tested (MOPC-104E, an IgM; MOPC-21A, an IgGl;
and T15, an IgA) inhibited the binding of LPC-1 even at a 70:1 excess (wt/wt).
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FIG. 7.
￿
Binding of'15I-MPC-11 to cells as a function of MPC-11 concentration. 2 days after
plating, cells were washed, incubated for 3 h in serum-free L-15 medium at 37°C, and then
incubated at 4°C for 1 h with a constant amount of 1251-MPC-11(0.015,ug, 1.09 x 105 cpm) and
varying amounts ofunlabeled MPC-11 . The plates were washed in cold PBS and the bound
protein released with trypsin. (A) Percent of 125I-MPC-11 bound. ("-"),thioglycollate-
stimulated macrophages, 4 x 105 per well; and (O-O) C57BL/6J embryo fibroblasts, 1.7 x
105 per well . (B) Data of A replotted to determine the equilibrium constant (slope) and
number of binding-sites (abscissa intercept) . For r and c see Fig. 4.JAY C. UNKELESS AND HERMAN N. EISEN
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TABLE III
Equilibrium Constants and Number ofSites Per Cell on Normal and Thioglycollate-
Stimulated Macrophages and on Cells ofthe P388D, Line forIgG2a and IgG2b Myeloma
Proteins
Protein
LPC-1 (IgG2a, rc)
MPC-11 (IgG2b, a)
All assays were performed at 4°C. The number of cells per well at the termination of the
experiment were : P388D, cells, 1 x 108; thioglycollate macrophages, 5 x 105; and normal macro-
phages, 4 x 105.
When iodine labeled, moreover, none ofthese myeloma proteins bound any more
to macrophages than to mouse embryo fibroblasts.
The three types of macrophage tested did not differ in their affinity for the
IgG2a proteins or in their affinity for MPC-11 (IgG2b). However, normal and
P388D, macrophages had fewer sites per cell than the thioglycollate-stimulated
cells for both LPC-1 and MPC-11.
Discussion
The present study differs from previous work on mouse macrophage Fc
receptors in that it examined the binding of monomeric Igs, rather than aggre-
gated Igs (3) or Ig-coated RBCs [rosette formation (1, 13-17)]. Moreover, the use
of a simple and rapid technique for washing the cells made it feasible to remove
unbound Igs without significant loss of bound Igs through dissociation. This
made it possible to measure rates of association and dissociation, equilibrium
constants, andthe number of binding sites per cell with confidence. Comparison
of normal mouse peritoneal macrophages, thioglycollate-stimulated macro-
phages, and a macrophage cell line (P388D,) revealed that all three are similar
in their binding of mouse Igs. Of the five Ig classes examined, IgA, IgM, and
IgG1 were not bound significantly, IgG2a was bound with high affinity, and
IgG2b was bound with a 20-fold lower affinity. These observations confirm
results of Ralph et al. (3) who found that aggregated IgG2a and IgG2b were
cytophilic. However, they conflict with the results of Cline et al. (17) who
reported that only IgG2a, and to a lesser extent IgG1, can compete for the
binding and phagocytosis of IgG-coated RBCs. Askenase and Hayden (16) sug-
gest that in addition to receptors for IgG2a, there may be receptors for mono-
meric IgM on macrophages.
Berken and Benacerraf (18) found that the Fc fragment was responsible for
the cytophilic properties of guinea pig IgG2, and others have since found that
the Fc fragment of cytophilic Igs can inhibit binding and phagocytosis of Ig-
coated RBCs (19) and bindingof iodinated cytophilic Ig (20). Two observations in
Type ofmacrophage Ka
(M-')
Sites per cell
P388D, 1.3 x 108 84,000
Thioglycollate-stimulated 1.3 x 108 440,000
Normal 1.4 x 108 110,000
P3881), 7.5 x 108 110,000
Thioglycollate-stimulated 9.0 x 108 290,000
Normal 6.8 x 108 50,0001530
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this study established that the cell receptors for monomeric Ig were specific for
Ig constant domains: (a) two IgG2a proteins (LPC-1 and 5563) that differed
considerably in their isoelectric points, doubtlessly because of differences in
their variable regions, were bound with the same affinity; and (b) with one of
these proteins, LPC-1, the Fc fragment was bound and the Fab fragments were
not.
The affinity of IgM for macrophage surface receptors is unclear. Ralph et al.
(3) found no detectable binding of 125I-aggregated IgM; and in the present study
macrophages were no more effective than embryonic mouse fibroblasts in bind-
ing unaggregated IgM. Cline et al . (17) found, in addition, that RBCs coated
with IgM did not bind to mouse macrophages. However, Lay and Nussenzweig
(13) have reported that sheep RBCs (SRBCs)coated with 19S antibodies to SRBC
form rosettes with macrophages, and Askenase and Hayden (16) described
partial inhibition ofrosette formation by antisera to IgM. While there are some
obvious contradictions, it remains possible that the binding of antigens induces
a conformational change in the Fc domain of IgM proteins (21), and that this is
required for significant binding of IgM molecules to macrophage receptors.
The present study clearly shows that the macrophage receptors for the Fc of
IgG2a proteins are readily inactivated by trypsin. Other studies suggest, how-
ever, that Fc receptors for Igs may differ in trypsin sensitivity. Kossard and
Nelson (15) reported that the receptors for cytophilic antibodies from early
antisera to SRBCs were trypsin sensitive and that the receptors for cytophilic
antibodies from late antisera were trypsin resistant. Similar findings were
noted with the early and late antisera to oxazolone (16). Others have observed,
with hyperimmune sera, that receptors for antibody-coated RBCs (13) and for
antibody-antigen complexes (22) are entirely trypsin resistant. There may well
be more than one type of Fc receptor on macrophages. The trypsin-sensitive
receptors characterized in the present work probably correspond to those that
bind cytophilic antibodies from early antisera; trypsin-resistant Fc receptors
could have quite different properties.
Fc receptors on guinea pig macrophages have been shown to bind guinea pig
IgG2, not IgG1 (18). The guinea pig cells bound IgG2 molecules with lower
affinity and at more binding sites per cell (23, 24) than we observed here with
mouse macrophages and mouse IgG2a molecules. (At 20°C, the values for
stimulated guinea pig macrophages were 1.5 x 106 M-1 and 2.5 x 106 sites per
cell vs. 7 x 107 M-1 and 4 x 105 sites per cell for the mouse system.) The
similarities are great enough to suggest that there is considerable structural
homology between guinea pig IgG2 and mouse IgG2a and IgG2b molecules. The
differences could derive from the use of different procedures for measuring
binding or from the use of homogeneous myeloma proteins in the mouse system
and an IgG electrophoretic fraction in the guinea pig system (the latter could
well include several classes as different as mouse IgG2a and IgG2b) .
Each of the mouse macrophage types examined in the present study had the
same affinity for monovalent mouse IgG2a (2 x 107 M-1 at 37°C); hence, with
unboundIgG2a at a concentration of 7 p,g/ml, receptors on the cell surface would
be half saturated. Since IgG2a is doubtlessly present in blood at a much higher
concentration, the corresponding Fc receptors of macrophages are probablyJAY C . UNKELESS AND HERMAN N. EISEN
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saturated in vivo. From the number ofFc receptors per cell, the surface area of
an unstimulated peritoneal macrophage (1,000 Wm2) (R. Steinman, personal
communication), and the cross-sectional area of a 7S Ig molecule, it can be
calculated that about 1% of the cell surface is covered with IgG2a molecules
when the corresponding receptors are saturated. Though the three cell types
have the same affinity for IgG2a, there are fourfold more binding sites on
thioglycollate-stimulated than on normal or P388D, macrophages. The differ-
ence is probably due to the greater size and surface area ofthe stimulated cells.
From the equilibrium constants and rate constants fordissociation, the bimo-
lecular association rate constants for the binding of IgG2a to mouse macro-
phages are readily obtained. At 4°C, this value is 0.9 x 107 M-1min'. This
constant and the measured dissociation rate constant at this temperature (0.08
min-, Table I) are both similar to the kinetic constants for representative
antibody-antigen reactions in solution. Dandliker and Levison (25), forinstance,
found the forward and reverse rate constants for the reaction of fluorescein-
labeled ovalbumin with rabbit antibodies to ovalbumin at 1.5°C to be 1.2 x 107
M-1min-1 and 0.06 min- . Due to cooperative binding effects (24, 26), even more
stable complexes are likely to result from the formation of aggregates that
contain many antibody and many antigen molecules. In the macrophage mem-
brane, however, bound monomeric IgG2a molecules are unlikely to form large,
multimolecular aggregates with Fc receptors, since the equilibrium constants
were independent of IgG2a concentration. (Even if the Fc receptors are fully
mobile in the membrane, there are unlikely to be more than one or twobinding
sites per Fc domain of IgG2a.) Large aggregates could be formed in the cell
membrane, however, ifmultivalent antigen particles were to cross-link IgG2a
molecules before or after the latter are bound to Fc receptors.
While the IgG2a/Fc complex is relatively stable, the halftime for dissociation
is stillfairly rapid(2.6min at37°C, TableI). This suggeststhatunderphysiologi-
cal conditions the macrophage surface is in a dynamic steady state, binding and
releasing IgG2a molecules rapidly enough to allow the cell's antigen-binding
capabilities to mirror the specificities of free IgG2a molecules in the cell's
immediate microenvironment. The binding properties of the macrophage Fc
receptors seem well adapted to support the cell's capacity to bind, presumably
via Ig molecules, an almost limitless variety of foreign antigens.
Summary
The binding properties of surface receptors of immunoglobulins on mouse
macrophages were studied with mouse myeloma proteins and normal peritoneal
macrophages, thioglycollate-stimulated macrophages, and a macrophage cell
line, P388D,. Primary cultures ofmouse embryo fibroblasts served as controls.
IgG2a proteins were bound strongly; IgG2b was boundweakly (one-twentieth as
well as IgG2a); IgM, IgA, and IgG1 were notboundsignificantly. Thenumber of
binding sites per cell for IgG2a was 4 x 105 for thioglycollate-stimulated cells
and 1 x 105 for normal and P388D, cells. Bindingwas exothermal : with decreas-
ing temperature the equilibrium (association) constants increased and dissocia-
tion rate constants decreased (at 37°C the respective values were 2 x 107 M-1
and 0.26 min-'; the latter value corresponds to a halftime for dissociation of2.61532
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min) . From the rapidity of association and dissociation, it appears that the
surface ofthe macrophage is in a dynamic equilibrium with IgG2a molecules in
the cell's immediate microenvironment.
The receptors for IgG2a are clearly specific for determinants in the immuno-
globulin constant domain: two IgG2a proteins with greatly different isoelectric
points (determined by isoelectric focusing) were bound with the same affinity to
the same receptors; moreover, the Fc fragment was bound and Fab fragments
were not. The Fc receptors for IgG2a proteins were readily eliminated by
exposing macrophages brieflyto trypsin. The receptors were regenerated during
subsequent cultivation in serum-free medium; regeneration was inhibited to-
tally by cycloheximide and partially by actinomycin D.
Received forpublication 29 July 1975.
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